- Home
- Publications
- Publication Search
- Publication Details
Title
Early Radiographic Progression of Scleroderma
Authors
Keywords
-
Journal
CHEST
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-08
DOI
10.1016/j.chest.2021.11.033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease
- (2020) Takashi Nawata et al. RHEUMATOLOGY
- Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Dinesh Khanna et al. Lancet Respiratory Medicine
- Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
- (2019) Oliver Distler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
- (2018) Suzanne Kafaja et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
- (2018) Elizabeth R Volkmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
- (2017) Nicole S. Goh et al. Arthritis & Rheumatology
- Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study
- (2016) Tetsuro Araki et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment
- (2016) Hyun J Kim et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
- (2016) Steven D Nathan et al. THORAX
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
- (2016) Donald P Tashkin et al. Lancet Respiratory Medicine
- Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) -- Report from OMERACT CTD-ILD Working Group
- (2015) D. Khanna et al. JOURNAL OF RHEUMATOLOGY
- Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis
- (2014) Donald P Tashkin et al. ANNALS OF THE RHEUMATIC DISEASES
- Quantitative imaging biomarkers: A review of statistical methods for computer algorithm comparisons
- (2014) Nancy A Obuchowski et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease
- (2011) Michael D. Roth et al. ARTHRITIS AND RHEUMATISM
- Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide
- (2011) Hyun J. Kim et al. EUROPEAN RADIOLOGY
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
- (2010) A. J. Tyndall et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now